Treating advanced/metastatic urothelial carcinoma: recent developments in the BGJ398 clinical trial
The open questions surrounding immunotherapy and targeted therapy in lung cancer
Advancements in use of combination drugs in clinical trials: nivolumab, pembrolizumab, and more
Avelumab in locally advanced or metastatic solid tumors
James L. Gulley
How can we optimize contemporary bladder cancer care?